{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/73475-3102#drug","name":"VYVGART Hytrulo","alternateName":"efgartigimod alfa and hyaluronidase (human recombinant)","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"73475-3102"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761304"},{"@type":"PropertyValue","propertyID":"UNII","value":"961YV2O515|743QUY4VD8"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"7104d9e5-9910-47f5-9a93-741ac50f43b6"}],"activeIngredient":"EFGARTIGIMOD ALFA, HYALURONIDASE (HUMAN RECOMBINANT)","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"argenx US"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761304","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7104d9e5-9910-47f5-9a93-741ac50f43b6","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73475-3102"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T15:21:27.994Z"}}